Australia markets closed

USANA Health Sciences, Inc. (USNA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
46.71+0.39 (+0.84%)
At close: 04:00PM EDT
46.71 0.00 (0.00%)
After hours: 06:03PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 889.85M
Enterprise value 562.84M
Trailing P/E 14.55
Forward P/E 18.18
PEG ratio (5-yr expected) 1.51
Price/sales (ttm)1.00
Price/book (mrq)1.78
Enterprise value/revenue 0.90
Enterprise value/EBITDA 6.94

Trading information

Stock price history

Beta (5Y monthly) 0.94
52-week change 3-28.41%
S&P500 52-week change 326.27%
52-week high 369.60
52-week low 341.45
50-day moving average 346.33
200-day moving average 351.99

Share statistics

Avg vol (3-month) 386.92k
Avg vol (10-day) 388.54k
Shares outstanding 519.05M
Implied shares outstanding 619.05M
Float 89.99M
% held by insiders 141.69%
% held by institutions 156.51%
Shares short (15 Apr 2024) 4260.23k
Short ratio (15 Apr 2024) 42.73
Short % of float (15 Apr 2024) 42.30%
Short % of shares outstanding (15 Apr 2024) 41.35%
Shares short (prior month 15 Mar 2024) 4255.09k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 323 Nov 2016

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2023
Most-recent quarter (mrq)30 Mar 2024

Profitability

Profit margin 6.88%
Operating margin (ttm)10.83%

Management effectiveness

Return on assets (ttm)9.20%
Return on equity (ttm)12.97%

Income statement

Revenue (ttm)900.45M
Revenue per share (ttm)46.84
Quarterly revenue growth (yoy)-8.30%
Gross profit (ttm)N/A
EBITDA 103.46M
Net income avi to common (ttm)61.94M
Diluted EPS (ttm)3.21
Quarterly earnings growth (yoy)-10.00%

Balance sheet

Total cash (mrq)328.34M
Total cash per share (mrq)17.24
Total debt (mrq)1.32M
Total debt/equity (mrq)0.26%
Current ratio (mrq)3.74
Book value per share (mrq)26.25

Cash flow statement

Operating cash flow (ttm)75.49M
Levered free cash flow (ttm)65.11M